2017 Cell Surface Markers: Emerging Opportunities, Country Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan

March 2017 | 120 pages | ID: 2E8930B482AEN
Venture Planning Group

Abstracts

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next ten years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself.

This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5- and 10-year test volume forecasts by country and market segment.

The report examines market applications of monoclonal antibodies, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

Contains 120 pages and 15 tables

Contents

I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Lymphocyte Subclassification CD4/CD8/CD34
  Instrumentation and Reagent Test Kits
    BD FACS Count
    Beckman Coulter VCS
    T Cells Diagnostics TRAx
B. Other Cell Markers
C. Instrumentation Review
  1. Hematology Analyzers
    a. Overview
      Electrical Aperture-Impedance Analyzers
      Light Scatter Analyzers
    b. System Review
      Abbott Cell-Dyn 3000
      Abbott Cell-Dyn 3200
      Abbott Cell-Dyn 3500
      Abbott Cell-Dyn 3700
      Abbott Cell-Dyn Ruby
      Abbott Cell-Dyn Sapphire
      Abbott Cell-Dyn Emerald
      Beckman Coulter HmX
      Beckman Coulter LH 500
      Beckman Coulter LH 750
      Beckman Coulter LH 780
      Beckman Coulter LH 1500
      Beckman Coulter STKS
      Beckman Coulter UniCell DxH 800
      Horiba ABX Helios LMG/5DIFF
      Horiba ABX Pentra Series
      Siemens ADVIA/H Series
      Siemens Advia 120
      Siemens Advia 2120i
      Sysmex XE-2100
      Sysmex XE-5000
      Sysmex XE-AlphaN
      Sysmex HST-N
      Sysmex NE-8000
      Sysmex SE-9000
      Sysmex XT Series
  2. Flow Cytometers
    a. Introduction
    b. System Overview
      Beckman Coulter Epics Profile
      Beckman Coulter Epics XL
      BD FACSadvantage
      BD FACSAria III
      BD FACScan
      BD FACSCanto II
      BD FACSCalibur
      BD FACSCount
      BD Influx
      BD FACStar Series
      BD FACSort
      BD FACStrak
      BD FACS Vantage
      Beckman Coulter Epics Elite ESP
      Beckman Coulter Epics Elite Analyzer
      Beckman Coulter Epics C
      Beckman Coulter FC 500 Series
      Beckman Coulter Vi-CELL XR
D. Current Market Needs and Future Demand for Hematology Analyzers
E. Reagents and Controls
F. Current and Emerging Technologies
  1. Information Technologies
  2. Automation and Robotics
  3. Lasers
  4. Artificial Intelligence
  5. Monoclonal Antibodies
  6. Molecular Diagnostics
  7. Microdrop Technology

III. FRANCE: FORECASTS BY TEST AND MARKET SEGMENT

IV. GERMANY: FORECASTS BY TEST AND MARKET SEGMENT

V. ITALY: FORECASTS BY TEST AND MARKET SEGMENT

VI. JAPAN: FORECASTS BY TEST AND MARKET SEGMENT

VII. SPAIN: FORECASTS BY TEST AND MARKET SEGMENT

VIII. U.K.: FORECASTS BY TEST AND MARKET SEGMENT

IX. U.S.: FORECASTS BY TEST AND MARKET SEGMENT

X. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for the Decentralized Testing Markets
  1. Four Marketing Approaches
  2. Product Complexity Factor
  3. Customer Preference Factor
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation Factor

XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XII. COMPETITIVE ASSESSMENTS

Abbott
Beckman Coulter
Becton Dickinson
Bio-Rad
DakoCytomation
Horiba
Iris
J&J Diagnostics
Nihon Kohden
Roche
Siemens
Sysmex

XIII. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING HEMATOLOGY/FLOW CYTOMETRY TECHNOLOGIES AND APPLICATIONS

List Of Tables

LIST OF TABLES

France, Hospital Laboratories Estimated Cell Surface Marker Test Volume
France, Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
Germany, Hospital Laboratories Estimated Cell Surface Marker Test Volume
Italy, Hospital Laboratories Estimated Cell Surface Marker Test Volume
Italy, Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
Japan, Hospital Laboratories Estimated Cell Surface Marker Test Volume
Japan, Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
Spain, Hospital Laboratories Estimated Cell Surface Marker Test Volume
Spain, Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
Spain, Ambulatory Care Center Estimated Cell Surface Marker Test Volume
U.K., Hospital Laboratories Estimated Cell Surface Marker Test Volume
U.K., Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
U.S., Hospital Laboratories Estimated Cell Surface Marker Test Volume
U.S., Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
U.S., Physician Office Laboratories Estimated Cell Surface Marker Test Volume